Chiesi and Bioasis to host a rare disease webcast
GUILFORD, CONN., U.S.A. and PARMA, ITALY – BIOASIS TECHNOLOGIES INC. (“ Bioasis ”) (TSXV:BTI.V; OTCQB:BIOAF), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB 3 TMplatform technology for the delivery of therapeutics across the blood-brain barrier (“ BBB ”) and…